logo-loader

Milestone Scientific reveals study that shows the cost-effectiveness of its CompuFlo Epidural System

Published: 12:49 20 Apr 2020 EDT

Milestone Scientific Inc (NYSEAMERICAN:MLSS) CEO Len Osser tells Proactive a study was presented at the American Society of Regional Anesthesia and Pain Medicine that validates the cost benefits of Milestone's CompuFlo Epidural System.

What's more, Osser says, is the company recently raised $5M gross to give it more than a one year's runway in the event the coronavirus continues to be widespread. Osser also says a large hospital recently contacted the company, as it was interested to begin trialing its cath check product this week to limit multiple contact between doctors and post-partum patients.

Novo Resources sees substantial upside potential at Nunyerry

Novo Resources Corp (TSX:NVO, OTCQX:NSRPF, ASX:NVO) co-chair and acting CEO Mike Spreadborough joins Jonathan Jackson in the Proactive studio to discuss promising gold outcomes from recent reanalysis of drill intercepts in a 2023 program at Nunyerry North in Western Australia. Using advanced...

11 hours, 17 minutes ago